GlassScriptPhysician profile
Stacy W Slade
NPI 1669996567
$8,029.80
in general payments reported to CMS, 2019-2025
35 companies · $997 in 2025
The $997 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,422 · 2022: $1,478 · 2023: $1,653 · 2024: $1,480 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,129.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,217.89 | 2021-2025 | General - Erectile Dysfunction, Lithovue |
| Sumitomo Pharma America, INC. | $1,305.97 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $667.82 | 2021-2024 | Provenge |
| Abbvie INC. | $529.52 | 2022-2025 | |
| Urovant Sciences INC | $370.11 | 2021-2022 | |
| Urogen Pharma, INC. | $360.09 | 2021-2025 | Jelmyto |
| Astellas Pharma US INC | $330.32 | 2021-2023 | Myrbetriq, Xtandi |
| Antares Pharma, INC. | $266.12 | 2021-2025 | Xyosted |
| Janssen Biotech, INC. | $263.87 | 2021-2025 | Erleada, Akeega |
| Endo Pharmaceuticals INC. | $260.66 | 2021-2024 | Xiaflex |
| Coloplast Corp | $231.77 | 2021-2025 | Speedicath |
| Myriad Genetic Laboratories, INC. | $162.41 | 2022-2025 | Prolaris |
| Pfizer INC. | $156.61 | 2022-2025 | |
| Myovant Sciences INC. | $115.99 | 2021-2022 | |
| Accord Healthcare, INC. | $85.10 | 2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $83.87 | 2021-2024 | |
| Endo USA, INC. | $63.45 | 2024-2025 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $62.80 | 2022-2023 | Keytruda, Welireg, Lynparza |
| Allergan, INC. | $51.72 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $49.07 | 2022-2023 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $41.18 | 2025 | |
| Immunitybio, INC. | $39.97 | 2024-2025 | |
| Amgen INC. | $37.87 | 2022 | |
| Hollister Incorporated | $37.72 | 2022-2023 | Vapro, Infyna Chic |
| Rochester Medical Corporation | $31.72 | 2022 | |
| 180 Medical, INC. | $30.92 | 2021-2025 | Gentlecath Glide |
| Sun Pharmaceutical Industries INC. | $25.53 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.96 | 2025 | |
| Tolmar, INC. | $21.54 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $20.64 | 2022 | |
| Therapeuticsmd, INC. | $19.54 | 2021 | |
| Palette Life Sciences, INC. | $17.18 | 2022 | |
| Halozyme INC | $16.69 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $16.31 | 2022 | |
| Femselect INC. | $13.87 | 2024 | Enplace |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Slade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.